According to reports, British scientists will conduct a study to determine the effectiveness of aspirin as a possible treatment for coronavirus.
According to the Recovery Trial trial website, among others, it will attempt to assess a variety of options, including low doses of dexamethasone, azithromycin, convulsant plasma and aspirin.
Focusing on aspirin will determine whether aspirin will help reduce the risk of blood clots in people with COVID-19, according to a Reuters report.
Patients infected with the virus due to hyper-reactive platelets most often suffer from blood clots, and aspirin is an antiplatelet agent.
Organizer fined $ 13g for UK defender coronavirus sanctions
At least 2,000 patients are expected to take part in what will be one of the UK’s largest tests. Each participant will receive 150 mg. Daily aspirin dose. Those patients will be compared with 2,000 others who receive only standard treatment.
The study will primarily focus on patient mortality after 28 days while also assessing the duration of hospital stays and the need for ventilation, Politico reported.
Europe celebrates with fireworks, with church bells
“Aspirin is widely used to prevent blood clots from forming in pregnant women in other conditions, including heart attack, stroke and pre-eclampsia,” said co-lead investigator Prof. Said Martin Landre.
“But enrolling patients in a randomized trial, such as recovery, is the only way to assess whether there are clear benefits for Covid-11 patients and whether those benefits may outweigh any potential side effects, such as the risk of bleeding.”
Other treatments tested in the retrieval trial included antibody-rich plasma collected from recovered COVID-19 patients, and Regeneron’s antibody cocktail used to treat Dogren Trump’s COVID-19 symptoms.
Click here for the Fox News app
It may take months to determine the results of these tests, but if aspirin proves effective, it will be a cheaper option to help control symptoms.
